Proxy Votes Now

Home › Funds › Legg Mason › ClearBridge Select Fund

ClearBridge Select Fund (CBSCX) proxy voting record 2025-2026

Fund family: Legg Mason · Filed by LEGG MASON PARTNERS INVESTMENT TRUST (CIK 880366) · SEC series S000039065

Share classes and tickers: CBSCX (C000120106), LBFIX (C000120108), LCBSX (C000120105), LCLAX (C000120103), LCLCX (C000120104), LCSSX (C000120107)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 773 with, 30 against, 0 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 10 FOR, 20 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Legg Mason as a whole

The same two figures as Legg Mason’s manager page (40,739 ballot items across 48 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsLegg MasonItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)97.7%74596.0%35,214
Backed environmental and social shareholder proposals at US companiesn/a147.8%995

Where this fund voted differently from most Legg Mason funds

Each ballot item this fund voted is set against the votes of the other Legg Mason funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Legg Mason funds on 5 items (0.9% of the 533 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Legg Mason fundsMgmtResult
Regeneron Pharmaceuticals, Inc.2026-06-12Election of Directors: Christine A. PoonForAGAINST — 4 of 4 Legg Mason fundsForElected, 76.8% support
Regeneron Pharmaceuticals, Inc.2026-06-12Election of Directors: Craig B. Thompson, M.D.ForAGAINST — 4 of 4 Legg Mason fundsForElected, 79.3% support
Regeneron Pharmaceuticals, Inc.2026-06-12Election of Directors: Joseph L. Goldstein, M.D.ForAGAINST — 4 of 4 Legg Mason fundsForElected, 70.1% support
Expedia Group, Inc.2026-06-17Election of Directors: Barry DillerForWITHHOLD — 4 of 5 Legg Mason fundsForPassed (calculated), 80.2% support
Expedia Group, Inc.2026-06-17Election of Directors: Dara KhosrowshahiForWITHHOLD — 3 of 5 Legg Mason fundsForPassed (calculated), 87.4% support

Download all 5 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 91.4% of this fund’s 803 such votes could be given a sector; the other 69 (8.6%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Technology225188.0%
Consumer Discretionary18152.8%
Finance7422.7%
Industrials7111.4%
Health Care6511.5%
Utilities4312.3%
Consumer Staples3800.0%
Energy2600.0%
Basic Materials600.0%
Real Estate500.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections5610
Audit-related750
Say-on-Pay720
Corporate Governance4015
Compensation300
Capital Structure130
Other Social Issues77
Environment or Climate55
Extraordinary Transactions30
Human Rights or Human Capital/workforce33

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Apple Inc.February 24, 2026$221M121
Microsoft CorporationDecember 5, 2025$191M216
NVIDIA CorporationJune 24, 2026$177M164
Casey's General Stores, Inc.September 3, 2025$128M151
Performance Food Group CompanyNovember 19, 2025$127M150
Charles River Laboratories International, Inc.May 5, 2026$79M150
L3Harris Technologies, Inc.May 11, 2026$74M141
Lam Research CorporationNovember 4, 2025$67M161

Notable votes against management

MeetingCompanyProposalFundMgmt
February 24, 2026Apple Inc.A shareholder proposal entitled "China Entanglement Audit" Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationEuropean Security Program Censorship Risk Audit Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationReport on Risks of Censorship in Generative Artificial Intelligence Shareholder proposalAgainstFor
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposalForAgainst
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposalAgainstFor
September 3, 2025Casey's General Stores, Inc.Shareholder proposal regarding Scope 3 greenhouse gas reduction targets. Shareholder proposalAgainstFor
May 11, 2026L3Harris Technologies, Inc.Shareholder Proposal titled "Improve Shareholder Ability to Call for a Special Shareholder Meeting". Shareholder proposalForAgainst
November 4, 2025Lam Research CorporationStockholder proposal titled "Realistic Shareholder Ability to Call for a Special Shareholder Meeting," if properly presented. Shareholder proposalForAgainst
June 3, 2026AppLovin CorporationStockholder proposal regarding disclosure of voting results by class of shares, if properly presented at the meeting. Shareholder proposalAgainstFor
May 15, 2026Intercontinental Exchange, Inc.A stockholder proposal regarding independent board chairman, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
June 1, 2026DocuSign, Inc.A stockholder proposal to report on the risks of non-fiduciary executive compensation metrics, if properly presented at the meeting Shareholder proposalAgainstFor
May 29, 2026Lowe's Companies, Inc.Shareholder Proposal requesting an independent board chairman. Shareholder proposalAgainstFor

Search this fund’s votes by company

813 ballot items at 80 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, ClearBridge Select Fund (CBSCX) voted at 80 shareholder meetings of 76 companies, on 813 ballot items in all. Where management made a recommendation, the fund followed it on 96.3% of the items and voted against it 30 times. Its most frequent area of disagreement was corporate governance (15 of its votes against management). It voted on 30 shareholder proposals. It voted FOR the board's own proposals more often than Legg Mason's funds as a whole (97.7% against 96.0%). It voted differently from most Legg Mason funds on 5 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Legg Mason’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.